Annual CFF
-$1.12 B
-$1.54 B-364.69%
30 June 2024
Summary:
ResMed annual cash flow from financing activities is currently -$1.12 billion, with the most recent change of -$1.54 billion (-364.69%) on 30 June 2024. During the last 3 years, it has fallen by -$354.65 million (-46.38%). RMD annual CFF is now -282.72% below its all-time high of $612.58 million, reached on 30 June 2016.RMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$150.76 M
+$242.53 M+61.67%
30 September 2024
Summary:
ResMed quarterly cash flow from financing activities is currently -$150.76 million, with the most recent change of +$242.53 million (+61.67%) on 30 September 2024. Over the past year, it has increased by +$88.20 million (+36.91%). RMD quarterly CFF is now -116.16% below its all-time high of $932.90 million, reached on 31 December 2022.RMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$1.12 B
+$375.00 K+0.03%
30 September 2024
Summary:
ResMed TTM cash flow from financing activities is currently -$1.12 billion, with the most recent change of +$375.00 thousand (+0.03%) on 30 September 2024. Over the past year, it has dropped by -$260.67 million (-30.37%). RMD TTM CFF is now -226.05% below its all-time high of $887.66 million, reached on 31 December 2022.RMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -364.7% | +36.9% | -30.4% |
| 3 y3 years | -46.4% | +30.8% | -181.4% |
| 5 y5 years | -292.8% | -10000.0% | -884.1% |
RMD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -364.7% | at low | -116.2% | +61.7% | -226.1% | +0.0% |
| 5 y | 5 years | -292.8% | at low | -116.2% | +61.7% | -226.1% | +0.0% |
| alltime | all time | -282.7% | at low | -116.2% | +74.4% | -226.1% | +0.0% |
ResMed Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$150.76 M(-61.7%) | -$1.12 B(-0.0%) |
| June 2024 | -$1.12 B(-364.7%) | -$393.28 M(+17.1%) | -$1.12 B(+22.4%) |
| Mar 2024 | - | -$335.91 M(+40.6%) | -$914.60 M(+6.6%) |
| Dec 2023 | - | -$238.96 M(+58.1%) | -$858.24 M(-373.7%) |
| Sept 2023 | - | -$151.13 M(-19.9%) | $313.62 M(-25.8%) |
| June 2023 | $422.87 M(-429.4%) | -$188.59 M(-32.5%) | $422.87 M(-36.8%) |
| Mar 2023 | - | -$279.56 M(-130.0%) | $668.96 M(-24.6%) |
| Dec 2022 | - | $932.90 M(-2327.6%) | $887.66 M(-437.2%) |
| Sept 2022 | - | -$41.88 M(-172.8%) | -$263.21 M(+105.1%) |
| June 2022 | -$128.36 M(-83.2%) | $57.50 M(-194.5%) | -$128.36 M(-57.2%) |
| Mar 2022 | - | -$60.86 M(-72.1%) | -$299.90 M(-24.6%) |
| Dec 2021 | - | -$217.97 M(-334.5%) | -$397.58 M(-19.9%) |
| Sept 2021 | - | $92.97 M(-181.5%) | -$496.40 M(-35.1%) |
| June 2021 | -$764.63 M(+141.0%) | -$114.04 M(-28.1%) | -$764.63 M(-13.8%) |
| Mar 2021 | - | -$158.54 M(-50.0%) | -$886.96 M(+24.9%) |
| Dec 2020 | - | -$316.80 M(+80.8%) | -$710.03 M(+80.9%) |
| Sept 2020 | - | -$175.26 M(-25.9%) | -$392.47 M(+23.7%) |
| June 2020 | -$317.29 M(-154.6%) | -$236.37 M(-1385.2%) | -$317.29 M(+77.8%) |
| Mar 2020 | - | $18.39 M(+2307.3%) | -$178.49 M(+57.0%) |
| Dec 2019 | - | $764.00 K(-100.8%) | -$113.70 M(-133.9%) |
| Sept 2019 | - | -$100.07 M(+2.6%) | $335.75 M(-42.2%) |
| June 2019 | $580.64 M(-156.6%) | -$97.58 M(-217.3%) | $580.64 M(+548.4%) |
| Mar 2019 | - | $83.18 M(-81.5%) | $89.55 M(-133.1%) |
| Dec 2018 | - | $450.21 M(+210.9%) | -$270.15 M(-65.2%) |
| Sept 2018 | - | $144.82 M(-124.6%) | -$775.79 M(-24.4%) |
| June 2018 | -$1.03 B(+290.6%) | -$588.67 M(+112.9%) | -$1.03 B(+83.4%) |
| Mar 2018 | - | -$276.52 M(+398.9%) | -$559.92 M(+66.5%) |
| Dec 2017 | - | -$55.42 M(-47.8%) | -$336.32 M(+2.3%) |
| Sept 2017 | - | -$106.08 M(-13.0%) | -$328.90 M(+25.1%) |
| June 2017 | -$262.87 M(-142.9%) | -$121.89 M(+130.3%) | -$262.87 M(-146.4%) |
| Mar 2017 | - | -$52.92 M(+10.3%) | $567.08 M(-6.1%) |
| Dec 2016 | - | -$48.00 M(+19.9%) | $603.86 M(+29.0%) |
| Sept 2016 | - | -$40.05 M(-105.7%) | $468.13 M(-23.6%) |
| June 2016 | $612.58 M(-339.5%) | $708.05 M(-4486.7%) | $612.58 M(-284.5%) |
| Mar 2016 | - | -$16.14 M(-91.2%) | -$332.03 M(-2.9%) |
| Dec 2015 | - | -$183.73 M(-276.0%) | -$341.93 M(+131.9%) |
| Sept 2015 | - | $104.41 M(-144.1%) | -$147.42 M(-42.4%) |
| June 2015 | -$255.79 M(-14.0%) | -$236.56 M(+808.5%) | -$255.79 M(+60.4%) |
| Mar 2015 | - | -$26.04 M(-341.6%) | -$159.46 M(-42.6%) |
| Dec 2014 | - | $10.78 M(-371.8%) | -$277.86 M(-10.7%) |
| Sept 2014 | - | -$3.96 M(-97.2%) | -$311.24 M(+4.7%) |
| June 2014 | -$297.32 M(+93.2%) | -$140.24 M(-2.9%) | -$297.32 M(+8.7%) |
| Mar 2014 | - | -$144.43 M(+538.9%) | -$273.55 M(+71.4%) |
| Dec 2013 | - | -$22.61 M(-327.0%) | -$159.56 M(+5.2%) |
| Sept 2013 | - | $9.96 M(-108.6%) | -$151.66 M(-1.5%) |
| June 2013 | -$153.93 M(-13.1%) | -$116.47 M(+282.7%) | -$153.93 M(+82.5%) |
| Mar 2013 | - | -$30.43 M(+106.9%) | -$84.34 M(-6.2%) |
| Dec 2012 | - | -$14.71 M(-291.3%) | -$89.88 M(+5.2%) |
| Sept 2012 | - | $7.69 M(-116.4%) | -$85.47 M(-51.7%) |
| June 2012 | -$177.10 M(+123.2%) | -$46.89 M(+30.4%) | -$177.10 M(+18.3%) |
| Mar 2012 | - | -$35.97 M(+249.0%) | -$149.77 M(+10.8%) |
| Dec 2011 | - | -$10.31 M(-87.7%) | -$135.14 M(+6.6%) |
| Sept 2011 | - | -$83.94 M(+329.3%) | -$126.80 M(+59.8%) |
| June 2011 | -$79.34 M(+29.8%) | -$19.55 M(-8.4%) | -$79.34 M(-20.2%) |
| Mar 2011 | - | -$21.34 M(+984.9%) | -$99.44 M(+68.1%) |
| Dec 2010 | - | -$1.97 M(-94.6%) | -$59.16 M(-25.7%) |
| Sept 2010 | - | -$36.48 M(-8.0%) | -$79.60 M(+30.2%) |
| June 2010 | -$61.13 M | -$39.65 M(-309.3%) | -$61.13 M(+110.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $18.94 M(-184.5%) | -$29.01 M(-49.0%) |
| Dec 2009 | - | -$22.41 M(+24.4%) | -$56.84 M(+244.0%) |
| Sept 2009 | - | -$18.01 M(+139.1%) | -$16.52 M(-983.2%) |
| June 2009 | $1.87 M(-102.9%) | -$7.53 M(-15.2%) | $1.87 M(-106.5%) |
| Mar 2009 | - | -$8.89 M(-149.6%) | -$28.66 M(-39.6%) |
| Dec 2008 | - | $17.90 M(+4526.1%) | -$47.42 M(-2.1%) |
| Sept 2008 | - | $387.00 K(-101.0%) | -$48.44 M(-24.0%) |
| June 2008 | -$63.76 M(-267.4%) | -$38.06 M(+37.7%) | -$63.76 M(+201.4%) |
| Mar 2008 | - | -$27.64 M(-263.7%) | -$21.15 M(-504.3%) |
| Dec 2007 | - | $16.89 M(-213.1%) | $5.23 M(-69.7%) |
| Sept 2007 | - | -$14.94 M(-429.0%) | $17.26 M(-54.7%) |
| June 2007 | $38.10 M(-61.0%) | $4.54 M(-460.5%) | $38.10 M(-45.3%) |
| Mar 2007 | - | -$1.26 M(-104.4%) | $69.62 M(-18.2%) |
| Dec 2006 | - | $28.92 M(+390.1%) | $85.07 M(+1.6%) |
| Sept 2006 | - | $5.90 M(-83.6%) | $83.75 M(-14.3%) |
| June 2006 | $97.77 M(+288.0%) | $36.06 M(+154.1%) | $97.77 M(+48.2%) |
| Mar 2006 | - | $14.19 M(-48.6%) | $65.97 M(-10.2%) |
| Dec 2005 | - | $27.60 M(+38.6%) | $73.50 M(+40.5%) |
| Sept 2005 | - | $19.91 M(+367.3%) | $52.31 M(+107.6%) |
| June 2005 | $25.20 M(+1817.5%) | $4.26 M(-80.4%) | $25.20 M(-4.4%) |
| Mar 2005 | - | $21.72 M(+238.9%) | $26.34 M(+232.9%) |
| Dec 2004 | - | $6.41 M(-189.1%) | $7.91 M(-154.6%) |
| Sept 2004 | - | -$7.20 M(-233.1%) | -$14.48 M(-1202.2%) |
| June 2004 | $1.31 M(-108.0%) | $5.41 M(+64.2%) | $1.31 M(-120.6%) |
| Mar 2004 | - | $3.29 M(-120.6%) | -$6.36 M(-24.7%) |
| Dec 2003 | - | -$15.98 M(-285.9%) | -$8.45 M(+193.5%) |
| Sept 2003 | - | $8.60 M(-478.6%) | -$2.88 M(-82.4%) |
| June 2003 | -$16.34 M(-22.8%) | -$2.27 M(-287.8%) | -$16.34 M(-62.0%) |
| Mar 2003 | - | $1.21 M(-111.6%) | -$43.00 M(-41.1%) |
| Dec 2002 | - | -$10.41 M(+114.3%) | -$73.06 M(+22.3%) |
| Sept 2002 | - | -$4.86 M(-83.2%) | -$59.75 M(+182.3%) |
| June 2002 | -$21.17 M(-115.2%) | -$28.94 M(+0.3%) | -$21.17 M(-117.7%) |
| Mar 2002 | - | -$28.84 M(-1096.3%) | $119.54 M(-28.2%) |
| Dec 2001 | - | $2.90 M(-91.4%) | $166.60 M(+2.1%) |
| Sept 2001 | - | $33.72 M(-69.8%) | $163.19 M(+17.4%) |
| June 2001 | $139.03 M(+2079.1%) | $111.77 M(+513.4%) | $139.03 M(+404.5%) |
| Mar 2001 | - | $18.22 M(-3624.4%) | $27.56 M(+115.0%) |
| Dec 2000 | - | -$517.00 K(-105.4%) | $12.82 M(-16.4%) |
| Sept 2000 | - | $9.55 M(+3095.3%) | $15.33 M(+140.3%) |
| June 2000 | $6.38 M(+235.8%) | $299.00 K(-91.4%) | $6.38 M(-0.0%) |
| Mar 2000 | - | $3.48 M(+74.1%) | $6.38 M(+99.4%) |
| Dec 1999 | - | $2.00 M(+233.3%) | $3.20 M(+100.0%) |
| Sept 1999 | - | $600.00 K(+100.0%) | $1.60 M(-15.8%) |
| June 1999 | $1.90 M(+137.5%) | $300.00 K(0.0%) | $1.90 M(+11.8%) |
| Mar 1999 | - | $300.00 K(-25.0%) | $1.70 M(0.0%) |
| Dec 1998 | - | $400.00 K(-55.6%) | $1.70 M(+30.8%) |
| Sept 1998 | - | $900.00 K(+800.0%) | $1.30 M(+62.5%) |
| June 1998 | $800.00 K(>+9900.0%) | $100.00 K(-66.7%) | $800.00 K(+14.3%) |
| Mar 1998 | - | $300.00 K(>+9900.0%) | $700.00 K(+75.0%) |
| Dec 1997 | - | $0.00(-100.0%) | $400.00 K(+33.3%) |
| Sept 1997 | - | $400.00 K(>+9900.0%) | $300.00 K(>+9900.0%) |
| June 1997 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 1996 | - | -$100.00 K(-200.0%) | $0.00(-100.0%) |
| Sept 1996 | - | $100.00 K | $100.00 K |
| June 1996 | $5.00 M(-76.3%) | - | - |
| June 1995 | $21.10 M(+3416.7%) | - | - |
| June 1994 | $600.00 K(+100.0%) | - | - |
| June 1993 | $300.00 K | - | - |
FAQ
- What is ResMed annual cash flow from financing activities?
- What is the all time high annual CFF for ResMed?
- What is ResMed annual CFF year-on-year change?
- What is ResMed quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ResMed?
- What is ResMed quarterly CFF year-on-year change?
- What is ResMed TTM cash flow from financing activities?
- What is the all time high TTM CFF for ResMed?
- What is ResMed TTM CFF year-on-year change?
What is ResMed annual cash flow from financing activities?
The current annual CFF of RMD is -$1.12 B
What is the all time high annual CFF for ResMed?
ResMed all-time high annual cash flow from financing activities is $612.58 M
What is ResMed annual CFF year-on-year change?
Over the past year, RMD annual cash flow from financing activities has changed by -$1.54 B (-364.69%)
What is ResMed quarterly cash flow from financing activities?
The current quarterly CFF of RMD is -$150.76 M
What is the all time high quarterly CFF for ResMed?
ResMed all-time high quarterly cash flow from financing activities is $932.90 M
What is ResMed quarterly CFF year-on-year change?
Over the past year, RMD quarterly cash flow from financing activities has changed by +$88.20 M (+36.91%)
What is ResMed TTM cash flow from financing activities?
The current TTM CFF of RMD is -$1.12 B
What is the all time high TTM CFF for ResMed?
ResMed all-time high TTM cash flow from financing activities is $887.66 M
What is ResMed TTM CFF year-on-year change?
Over the past year, RMD TTM cash flow from financing activities has changed by -$260.67 M (-30.37%)